- Home
- RSSS vs TLSA Comparison
RSSS vs TLSA Comparison
Compare RSSS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- TLSA
- Stock Information
- Founded
- RSSS 2006
- TLSA 2013
- Country
- RSSS United States
- TLSA United Kingdom
- Employees
- RSSS N/A
- TLSA N/A
- Industry
- RSSS Business Services
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- TLSA Health Care
- Exchange
- RSSS Nasdaq
- TLSA Nasdaq
- Market Cap
- RSSS 110.0M
- TLSA 187.0M
- IPO Year
- RSSS N/A
- TLSA 2000
- Fundamental
- Price
- RSSS $3.25
- TLSA $2.02
- Analyst Decision
- RSSS Strong Buy
- TLSA
- Analyst Count
- RSSS 1
- TLSA 0
- Target Price
- RSSS $5.00
- TLSA N/A
- AVG Volume (30 Days)
- RSSS 145.9K
- TLSA 428.6K
- Earning Date
- RSSS 11-13-2025
- TLSA 05-06-2025
- Dividend Yield
- RSSS N/A
- TLSA N/A
- EPS Growth
- RSSS N/A
- TLSA N/A
- EPS
- RSSS 0.04
- TLSA N/A
- Revenue
- RSSS $49,057,981.00
- TLSA N/A
- Revenue This Year
- RSSS $5.79
- TLSA N/A
- Revenue Next Year
- RSSS $8.46
- TLSA N/A
- P/E Ratio
- RSSS $81.75
- TLSA N/A
- Revenue Growth
- RSSS 9.94
- TLSA N/A
- 52 Week Low
- RSSS $2.32
- TLSA $0.63
- 52 Week High
- RSSS $4.24
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- RSSS 39.80
- TLSA 50.74
- Support Level
- RSSS $3.43
- TLSA $1.95
- Resistance Level
- RSSS $3.65
- TLSA $2.20
- Average True Range (ATR)
- RSSS 0.16
- TLSA 0.18
- MACD
- RSSS -0.07
- TLSA 0.00
- Stochastic Oscillator
- RSSS 0.00
- TLSA 27.89
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.